首页>Diabetes technology & therapeutics>Evaluation of a new reusable insulin pen (ClikSTAR) in Canadian patients with type 1 and type 2 diabetes mellitus receiving insulin glargine
Evaluation of a new reusable insulin pen (ClikSTAR) in Canadian patients with type 1 and type 2 diabetes mellitus receiving insulin glargine
作者单位：Sanofi-aventis, Laval, QC, Canada[1]Diabetes Research Group, Health Science Centre, Winnipeg, MB, Canada[2]Signature Medicine Centre Pharmacy, Calgary, AB, Canada[3]University of Toronto, Credit Valley Professional Building, 506-2300 Eglinton Ave. West[4]University of Sherbrooke, Sherbrooke, QC, Canada[5]Sanofi-Aventis Deutschland GmbH Industrialization, Partner and Device Management, Frankfurt am Main[6]ChronicDiseaseCare.ca Society of BC, Vancouver, BC, Canada[7]
换一批
